Nipocalimab granted U.S. FDA Priority Review for the treatment of generalized myasthenia gravis
J&J(JNJ) Prnewswire·2025-01-09 21:04J&J(JNJ) Prnewswire·2025-01-09 21:04
R1J&J(JNJ) Prnewswire·2025-01-09 21:04 R1J&J(JNJ) Prnewswire·2025-01-09 21:04